News
-
-
-
PRESS RELEASE
Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
First MVID patient enters active treatment extension phase with liquid crofelemer as adjunctive therapy. Jaguar Health focuses on rare pediatric disease treatment -
-
-
-
-
PRESS RELEASE
Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
The Vanguard Group, Inc. discloses 5.04% stake in Picton Property Income Limited as of 18 May 2026. Additional disclosures for a consortium involving LondonMetric Property plc and Schroder Real Estate Investment Trust Limited -
-